These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The clearance of theophylline is increased during the initial period of tuberculosis treatment. Ahn HC, Lee YC. Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703 [Abstract] [Full Text] [Related]
5. The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule. Zwolska Z, Augustynowicz-Kopeć E, Niemirowska-Mikulska H. Acta Pol Pharm; 2002 Jun; 59(6):448-52. PubMed ID: 12669769 [Abstract] [Full Text] [Related]
6. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
7. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers. Padgaonkar KA, Revankar SN, Bhatt AD, Vaz JA, Desai ND, D'Sa S, Shah V, Gandewar K. Int J Tuberc Lung Dis; 1999 Jul; 3(7):627-31. PubMed ID: 10423226 [Abstract] [Full Text] [Related]
8. [Pharmacodynamics and pharmacokinetics of domestic fixed-dose combination of antituberculosis drugs]. Zhao W, Li H, Duan L, Liang G, Zhang T, Lu Y. Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):333-6. PubMed ID: 12126555 [Abstract] [Full Text] [Related]
9. [Intermittent chemotherapy from the beginning or only after a period of daily administration? Quantitative bacteriological study at the initial phase of chemotherapy with INH + RMP + EMB in daily or intermittent administration]. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977 Jun; 26(4):193-205. PubMed ID: 204971 [Abstract] [Full Text] [Related]
10. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [Abstract] [Full Text] [Related]
15. [The effects of antituberculosis drugs on the pharmacokinetics of digitoxin (author's transl)]. Peters U, Hausamen TU, Grosse-Brockhoff F. Dtsch Med Wochenschr; 1974 Nov 22; 99(47):2381-6. PubMed ID: 4426257 [No Abstract] [Full Text] [Related]
16. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974. Engbaek HC, Heckscher T, Højgaard C, Larsen SO, Rasmussen KN, Vergmann B. Eur J Respir Dis; 1982 Mar 22; 63(2):84-93. PubMed ID: 7040100 [Abstract] [Full Text] [Related]
17. Effect of simultaneous isoniazid administration on pharmacokinetic parameters of pyrazinamide. Singhal KC, Varshney MK. J Indian Med Assoc; 1991 Aug 22; 89(8):227-9. PubMed ID: 1748799 [Abstract] [Full Text] [Related]
18. Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules. Zwolska Z, Niemirowska-Mikulska H, Augustynowicz-Kopec E, Walkiewicz R, Stambrowska H, Safianowska A, Grubek-Jaworska H. Int J Tuberc Lung Dis; 1998 Oct 22; 2(10):824-30. PubMed ID: 9783530 [Abstract] [Full Text] [Related]
19. Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children. Thee S, Detjen A, Quarcoo D, Wahn U, Magdorf K. Int J Tuberc Lung Dis; 2007 Sep 22; 11(9):965-71. PubMed ID: 17705973 [Abstract] [Full Text] [Related]
20. The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats. De Rosa HJ, Baldan HM, Brunetti IL, Ximenes VF, Machado RG. Biopharm Drug Dispos; 2007 Sep 22; 28(6):291-6. PubMed ID: 17571294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]